Kestra Investment Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Buy
2,723
+809
+42% +$373K 0.03% 177
2026
Q1
$919K Buy
+1,914
New +$980K 0.02% 225
2025
Q3
Sell
-42
Closed -$13.2K 633
2025
Q2
$13.2K Buy
42
+33
+367% +$9.91K ﹤0.01% 541
2025
Q1
$2.74K Sell
9
-1,096
-99% -$369K ﹤0.01% 739
2024
Q4
$367K Buy
1,105
+407
+58% +$138K 0.01% 278
2024
Q3
$233K Buy
+698
New +$265K 0.01% 299

Other funds holding MEDP

Kestra Investment Management's MEDP Position: Q2 2026 in Review

Kestra Investment Management increased its Medpace (MEDP) stake by 42% in Q2 2026, buying an estimated $373K and bringing the position to 2,723 shares worth $1.44M. The position accounts for 0.03% of the portfolio, ranked #177.

Kestra Investment Management first reported a position in MEDP in Q3 2024 and has held it in 6 quarters since. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Kestra Investment Management held 2,723 shares of Medpace worth $1.44M as of Q2 2026.
  • Kestra Investment Management bought 809 Medpace shares in Q2 2026, an estimated $373K.
  • Medpace made up 0.03% of Kestra Investment Management's portfolio in Q2 2026, its #177 holding.
  • Kestra Investment Management first reported a position in Medpace in Q3 2024 and has held it in 6 quarters since.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Kestra Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.